1. Home
  2. AHMA vs GANX Comparison

AHMA vs GANX Comparison

Compare AHMA & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AHMA

Ambitions Enterprise Management Co. L.L.C Class A Ordinary Shares

N/A

Current Price

$39.50

Market Cap

150.1M

ML Signal

N/A

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$2.08

Market Cap

159.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AHMA
GANX
Founded
2007
2017
Country
United Arab Emirates
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
150.1M
159.2M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
AHMA
GANX
Price
$39.50
$2.08
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.00
AVG Volume (30 Days)
2.5M
1.3M
Earning Date
12-08-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.04
N/A
Revenue
$19,771,050.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$667.02
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.00
$1.41
52 Week High
$31.07
$4.34

Technical Indicators

Market Signals
Indicator
AHMA
GANX
Relative Strength Index (RSI) N/A 39.13
Support Level N/A $1.75
Resistance Level N/A $2.26
Average True Range (ATR) 0.00 0.29
MACD 0.00 -0.06
Stochastic Oscillator 0.00 21.75

Price Performance

Historical Comparison
AHMA
GANX

About AHMA Ambitions Enterprise Management Co. L.L.C Class A Ordinary Shares

Ambitions Enterprise Management Co LLC, through its subsidiaries in the UAE, operates as a tour operator, travel agency, and event planning and management services provider. It provides two lines of services, namely, MICE management, a comprehensive coordination and organization of events, and one-stop tourism, a comprehensive travel product that is designed to provide tourists with all the necessary components of a trip in a single and convenient package, which typically include transportation, accommodations, meals, and guided tours or activities.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: